The FDA updated fluoroquinolone labeling to warn against routine use in patients with acute bacterial sinusitis, acute exacerbation of chronic bronchitis, and uncomplicated urinary tract infections.
News Alerts …read more
The FDA updated fluoroquinolone labeling to warn against routine use in patients with acute bacterial sinusitis, acute exacerbation of chronic bronchitis, and uncomplicated urinary tract infections.
News Alerts …read more